Hospital Radmission for COPD PatientsNCT06348966
Predictors of Hospital Readmission for Chronic Obstructive Pulmonary Disease Patients
An observational study of Hospital Radmission for COPD Patients, run by Assiut University.
Trial summary
This study is aimed to determine the risk factors for hospital readmission within 6 months in COPD patients Read more about this study
- Who is it for?
- Ages 25 to 80 years
- Conditions the study is for
- Hospital Radmission for COPD Patients
- How many people
- 188 participants
- Where
- No sites listed yet
- Study dates
- 1 May 2024to Jun 2026
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 80 years
- All sexes
- Adult, Older adult
Study population: this study is a prospective hospital-based cohort study
Who may be able to join
- All COPD patients of both genders diagnosed by (GOLD) Guidelines (2024 Revision).
- Cooprative patients who accept to participate in the current study .
Who cannot join
- patients with cognitive impairment ,and unable to answer needed questions.
- patients with other lung diseases such as active pulmonary tuberculosis ,asthma ,bronchiactesis,and pulmonary embolism .
- patients with incomplete clinical data .
- Refused to participate in the current study .
Trial locations and contacts
No sites are listed yet.
About this study
Official title: Predictors of Hospital Readmission for Chronic Obstructive Pulmonary Disease Patients,A Prospective Cohort Study
This study is aimed to determine the risk factors for hospital readmission within 6 months in COPD patients
Read the detailed description
This study is aimed to determine the risk factors for hospital readmission within 6 months in COPD patients and develop early warning model
- Conditions
- Hospital Radmission for COPD Patients
What is being measured
The primary outcome is the main question the study is designed to answer.
assessment of potential predictors of readmission among COPD patients
using CCI (charlson comorbidity index)
Measured: 6 months
Secondary outcomes (1)
development of early warning model for hospital readmission in COPD patients
using CCI (charlson comorbidity index)
Measured: within 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Apr 2024
- Study start1 May 2024 (estimated)
- Primary completionMay 2026 (estimated)
- Study completionJun 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Hospital Radmission for COPD PatientsStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 188 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Rougina Girgis Kamel Boles, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06348966
- Sponsor's protocol ID
- predictors of readmission
- Status last verified
- Mar 2024
- First submitted
- 25 Mar 2024
- Last updated
- 5 Apr 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Alqahtani JS, Aldabayan YS, Aldhahir AM, Al Rajeh AM, Mandal S, Hurst JR. Predictors of 30- and 90-Day COPD Exacerbation Readmission: A Prospective Cohort Study. Int J Chron Obstruct Pulmon Dis. 2021 Oct 7;16:2769-2781. doi: 10.2147/COPD.S328030. eCollection 2021.
PubMed 34675502Anbesse ZK, Mega TA, Tesfaye BT, Negera GZ. Early readmission and its predictors among patients treated for acute exacerbations of chronic obstructive respiratory disease in Ethiopia: A prospective cohort study. PLoS One. 2020 Oct 6;15(10):e0239665. doi: 10.1371/journal.pone.0239665. eCollection 2020.
PubMed 33022006
Study at a glance
From the registry record, last updated by the sponsor on 5 Apr 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Predictors of Hospital Readmission for Chronic Obstructive Pulmonary Disease Patients,A Prospective Cohort Study
- ClinicalTrials.gov ID
- NCT06348966
- Acronym / sponsor ID
- predictors of readmission
- Conditions
- Hospital Radmission for COPD Patients
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 188 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- 1 May 2024 (estimated)
- Primary completion
- May 2026 (estimated)
- Study completion
- Jun 2026 (estimated)
- First posted
- 5 Apr 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is aimed to determine the risk factors for hospital readmission within 6 months in COPD patients
Detailed description
This study is aimed to determine the risk factors for hospital readmission within 6 months in COPD patients and develop early warning model
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 25 to 80 years
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- this study is a prospective hospital-based cohort study
Key inclusion criteria (2 listed)
- All COPD patients of both genders diagnosed by (GOLD) Guidelines (2024 Revision).
- Cooprative patients who accept to participate in the current study .
Key exclusion criteria (4 listed)
- patients with cognitive impairment ,and unable to answer needed questions.
- patients with other lung diseases such as active pulmonary tuberculosis ,asthma ,bronchiactesis,and pulmonary embolism .
- patients with incomplete clinical data .
- Refused to participate in the current study .
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
assessment of potential predictors of readmission among COPD patients
Time frame: 6 months
using CCI (charlson comorbidity index)
1 secondary outcome
development of early warning model for hospital readmission in COPD patients
Time frame: within 6 months
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Apr 2024.
- Background: PubMed 34675502Alqahtani JS, Aldabayan YS, Aldhahir AM, Al Rajeh AM, Mandal S, Hurst JR. Predictors of 30- and 90-Day COPD Exacerbation Readmission: A Prospective Cohort Study. Int J Chron Obstruct Pulmon Dis. 2021 Oct 7;16:2769-2781. doi: 10.2147/COPD.S328030. eCollection 2021.
- Background: PubMed 33022006Anbesse ZK, Mega TA, Tesfaye BT, Negera GZ. Early readmission and its predictors among patients treated for acute exacerbations of chronic obstructive respiratory disease in Ethiopia: A prospective cohort study. PLoS One. 2020 Oct 6;15(10):e0239665. doi: 10.1371/journal.pone.0239665. eCollection 2020.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Questions about this trial
What is this clinical trial studying?
An observational study of Hospital Radmission for COPD Patients, run by Assiut University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 5 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Rougina Girgis (01273476615, rouginagirgis4@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
assessment of potential predictors of readmission among COPD patients (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06348966, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Apr 2024.